Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Blood|March 10, 2018
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locusChiara Antoniani, Vasco Meneghini, Annalisa Lattanzi, et al.
Haematologica|February 24, 2018
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusionChantal Lagresle-Peyrou, François Lefrère, Elisa Magrin, et al.
Blood|February 11, 2020
Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programsEmmanuelle Six, Agathe Guilloux, Adeline Denis, et al.
The New England Journal of Medicine|March 2, 2017
Gene Therapy in a Patient with Sickle Cell DiseaseJean-Antoine Ribeil, Salima Hacein-Bey-Abina, Emmanuel Payen, et al.
Molecular Therapy. Methods & Clinical Development|March 27, 2019
Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 Infected Patients with High-Risk LymphomaMarianne Delville, Fabien Touzot, Chloé Couzin, et al.
Cell Reports. Medicine|January 27, 2023
Severe hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapySteicy Sobrino, Alessandra Magnani, Michaela Semeraro, et al.
Transplantation and Cellular Therapy|June 13, 2026
Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French ExperienceUgo Chartral, Mony Fahd, Emma Gasperment, et al.
Nature Communications|April 1, 2025
Severe inflammation and lineage skewing are associated with poor engraftment of engineered hematopoietic stem cells in patients with sickle cell diseaseSteicy Sobrino, Laure Joseph, Elisa Magrin, et al.
Bone Marrow Transplantation|December 11, 2025
Securing raw materials, reagents, and consumable supplies in the academic bioproduction UNITC network: because the chain is only as strong as its weakest linkUgo Chartral, Jeanne Galaine, Camille Giverne, et al.
Nature Medicine|January 25, 2022
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trialElisa Magrin, Michaela Semeraro, Nicolas Hebert, et al.
Pageof 4